Renaissance Technologies - CYCLERION THERAPEUTICS INC ownership

CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 36 filers reported holding CYCLERION THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CYCLERION THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$38
-68.3%
86,700
-52.8%
0.00%
Q4 2022$120
-100.0%
183,580
-35.2%
0.00%
Q3 2022$244,000
-2.4%
283,388
-37.9%
0.00%
Q2 2022$250,000
-25.6%
456,077
+50.7%
0.00%
Q1 2022$336,000
-43.5%
302,558
-12.5%
0.00%
-100.0%
Q4 2021$595,000
+168.0%
345,900
+378.4%
0.00%
Q3 2021$222,000
-80.0%
72,300
-74.6%
0.00%
-100.0%
Q2 2021$1,111,000
+70.7%
284,744
+22.1%
0.00%0.0%
Q1 2021$651,000
+1083.6%
233,200
+1202.8%
0.00%
Q4 2020$55,000
-89.0%
17,900
-78.9%
0.00%
Q2 2020$502,000
+239.2%
85,000
+52.3%
0.00%
Q1 2020$148,00055,8010.00%
Other shareholders
CYCLERION THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Slate Path Capital LP 7,157,601$3,105,6830.15%
Artal Group S.A. 2,779,122$1,2060.07%
MFN Partners Management, LP 3,389,215$1,470,5800.07%
Intrinsic Value Partners, LLC 43,105$18,7030.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 115,000$49,8990.00%
Penobscot Investment Management Company, Inc. 10,000$4,3390.00%
COLONY GROUP LLC 102,884$440.00%
CAPTRUST FINANCIAL ADVISORS 292,645$126,9790.00%
GEODE CAPITAL MANAGEMENT, LLC 592,237$256,9710.00%
STATE STREET CORP 115,414$50,0780.00%
View complete list of CYCLERION THERAPEUTICS INC shareholders